Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05406258 · ClinicalTrials.gov registry record · NA
Self-Catheterization Mirror System for Female Patients
A NA study, sponsored by Shirley Ryan AbilityLab.
- Completed
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT05406258: Completed NA study, sponsored by Shirley Ryan AbilityLab.
NCT05406258 is a NA study that has completed, run by Shirley Ryan AbilityLab. The registered enrollment target is 2 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05406258, a NA study, has completed, sponsored by Shirley Ryan AbilityLab.
- COMPLETED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
The purpose of this study is to test a modified mirror system for female patients to use during self-catheterization.
Primary Outcome
Patient-reported usability and experience when using the mirror, with scores ranging from -20 to +20 (higher scores indicating higher usability performance). This assessment included 10 items with statements that participants scored on a Likert scale from strongly disagree (-2) to strongly agree (+2).
Interventions
- DEVICE Modified Self-Catheterization Mirror
- DEVICE Standard Self-Catheterization Mirror
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2022-01-11 |
| Est. Completion | 2022-03-31 |
| Phase | NA |
What the finished NCT05406258 record still lists
NCT05406258 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which Modified Self-Catheterization Mirror is the first listed.
NCT05406258 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05406258 about?
NCT05406258 is a clinical study titled "Self-Catheterization Mirror System for Female Patients". The purpose of this study is to test a modified mirror system for female patients to use during self-catheterization.
What is the current status of trial NCT05406258?
This trial is currently completed. It is a NA study. The enrollment target is 2 participants. The study started on 2022-01-11. Estimated completion is 2022-03-31.
What interventions are being tested in trial NCT05406258?
The interventions under investigation include: Modified Self-Catheterization Mirror (DEVICE), Standard Self-Catheterization Mirror (DEVICE).
Who is sponsoring clinical trial NCT05406258?
This trial is sponsored by Shirley Ryan AbilityLab, which has 138 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05406258's enrollment target sits among peer trials
2 1997th of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI